Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study

Bertrand Le Roy; Lucie Tixier; Bruno Pereira; Pierre Sauvanet; Emmanuel Buc; Caroline Pétorin; Pierre Déchelotte; Denis Pezet; David Balayssac

doi:10.1371/journal.pone.0148739

Loading metrics

Open Access

Peer-reviewed

Research Article

Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study

Bertrand Le Roy,

Affiliation CHU Clermont-Ferrand, Service de chirurgie et oncologie digestive, F-63003, Clermont-Ferrand, France
⨯
Lucie Tixier,

Affiliation CHU Clermont-Ferrand, Service d’anatomopathologie, F-63003, Clermont-Ferrand, France
⨯
Bruno Pereira,

Affiliation CHU Clermont-Ferrand, Délégation à la Recherche Clinique et à l’Innovation, F-63003, Clermont-Ferrand, France
⨯
Pierre Sauvanet,

Affiliations CHU Clermont-Ferrand, Service de chirurgie et oncologie digestive, F-63003, Clermont-Ferrand, France, INSERM/UdA U1071, USC INRA 2018, M2iSH, F-63001, Clermont-Ferrand, France
⨯
Emmanuel Buc,

Affiliations CHU Clermont-Ferrand, Service de chirurgie et oncologie digestive, F-63003, Clermont-Ferrand, France, INSERM/UdA U1071, USC INRA 2018, M2iSH, F-63001, Clermont-Ferrand, France
⨯
Caroline Pétorin,

Affiliation CHU Clermont-Ferrand, Service de chirurgie et oncologie digestive, F-63003, Clermont-Ferrand, France
⨯
Pierre Déchelotte,

Affiliations CHU Clermont-Ferrand, Service d’anatomopathologie, F-63003, Clermont-Ferrand, France, Université d’Auvergne, R2D2 – EA 7281, F-63001, Clermont-Ferrand, France
⨯
Denis Pezet,

Affiliations CHU Clermont-Ferrand, Service de chirurgie et oncologie digestive, F-63003, Clermont-Ferrand, France, INSERM/UdA U1071, USC INRA 2018, M2iSH, F-63001, Clermont-Ferrand, France
⨯
David Balayssac

* E-mail: dbalayssac@chu-clermontferrand.fr

Affiliations CHU Clermont-Ferrand, Délégation à la Recherche Clinique et à l’Innovation, F-63003, Clermont-Ferrand, France, INSERM U1107, Neuro-Dol, F-63001, Clermont-Ferrand, France
⨯

Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study

Bertrand Le Roy,
Lucie Tixier,
Bruno Pereira,
Pierre Sauvanet,
Emmanuel Buc,
Caroline Pétorin,
Pierre Déchelotte,
Denis Pezet,
David Balayssac

Published: February 9, 2016
https://doi.org/10.1371/journal.pone.0148739

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Adjuvant chemotherapy
Is the Subject Area "Adjuvant chemotherapy" applicable to this article?

Thanks for your feedback.
Immunostaining
Is the Subject Area "Immunostaining" applicable to this article?

Thanks for your feedback.
Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Tumor resection
Is the Subject Area "Tumor resection" applicable to this article?

Thanks for your feedback.